International investing analysts see upside potential in

Analysts see upside potential in international investing allocations to South Korean equities, driven by semiconductor exports rebounding 18% YoY in April. When you first look at it, Jin Medical International's ROE doesn't look that attractive. A quick further study shows that the company's ROE doesn't compare favorably to the industry average of 11% either. As a result, Jin Medical International reported a very low income growth of 3.2% over the past five years. Non-US stocks are outperforming this year, but there are both tactical and strategic reasons to buy international equities today. Global equity flows show rising allocations to Asia-Pacific markets, with the Nikkei 225 advancing 4% in the last two weeks. Traders cite semiconductor demand and yen weakness as key catalysts for this international investing trend.